Regulation of fibroblast growth factor-2 by an endogenous antisense RNA and by argonaute-2

Leigh-Ann MacFarlane1, Ying Gu, Alan G Casson

  • 1Department of Physiology and Biophysics, Faculty of Medicine, Dalhousie University, Halifax, Nova Scotia, Canada.

Insights

Fibroblast growth factor-2 (FGF-2) and its antisense RNA (FGF-AS) mutually regulate each other in lung adenocarcinoma cells. FGF-AS targets FGF-2 mRNA, influencing tumor recurrence and survival.

Area of Science:

  • Molecular Biology
  • Cancer Research
  • RNA Biology

Background:

  • Elevated fibroblast growth factor-2 (FGF-2) expression correlates with poor outcomes in esophageal cancer.
  • Coexpression of endogenous antisense (FGF-AS) RNA with FGF-2 is associated with reduced tumor recurrence and improved survival.

Purpose of the Study:

  • To investigate the regulatory role of endogenous FGF-AS in controlling FGF-2 expression within human lung adenocarcinoma cells (Seg-1).

Main Methods:

  • Utilized small interfering RNAs (siRNAs) to knock down FGF-2 and FGF-AS expression.
  • Employed a luciferase reporter system to analyze mRNA interactions.
  • Performed deletion mapping to identify specific RNA binding sites.
  • Assessed mRNA stability and protein expression levels.
  • Investigated the involvement of argonaute-2 (AGO-2) and micro-RNA pathways.

Main Results:

  • FGF-2 and FGF-AS were found to be colocalized in the cytoplasm and mutually regulate each other's expression and stability.
  • FGF-AS directly targets the 3'-untranslated region of FGF-2 mRNA.
  • Knockdown of FGF-AS led to decreased expression of AGO-2 and other RNA interference pathway components.
  • Knockdown of AGO-2 increased FGF-2 mRNA stability and protein levels, suggesting its role in FGF-2 regulation.

Conclusions:

  • Endogenous FGF-AS plays a critical role in regulating FGF-2 expression in lung adenocarcinoma through direct interaction with FGF-2 mRNA.
  • The FGF-2/FGF-AS axis and the AGO-2 protein are key components in the post-transcriptional regulation of FGF-2, impacting cancer progression.

Related Concept Videos

Experimental RNAi02:15

Experimental RNAi

RNA interference (RNAi) is a cellular mechanism that inhibits gene expression by suppressing its transcription or activating the RNA degradation process. The mechanism was discovered by Andrew Fire and Craig Mello in 1998 in plants. Today, it is observed in almost all eukaryotes, including protozoa, flies, nematodes, insects, parasites, and mammals. This precise cellular mechanism of gene silencing has been developed into a technique that provides an efficient way to identify and determine the...
Regulation of Angiogenesis and Blood Supply01:24

Regulation of Angiogenesis and Blood Supply

Rapidly dividing tumors, embryos, and wounded tissues require more oxygen than usual, lowering the oxygen concentration in the blood. At low oxygen or hypoxic conditions, an oxygen-sensitive transcription factor called the hypoxia-inducible factor 1 or HIF1 is activated. HIF1 is a dimeric protein of alpha (ɑ) and beta (β) subunits.  Under optimal oxygen conditions, HIF1β is present in the nucleus while HIF1ɑ remains in the cytosol. HIF1ɑ is hydroxylated by prolyl hydroxylase and factor...
siRNA - Small Interfering RNAs02:30

siRNA - Small Interfering RNAs

Small interfering RNAs, or siRNAs, are short regulatory RNA molecules that can silence genes post-transcriptionally, as well as the transcriptional level in some cases. siRNAs are important for protecting cells against viral infections and silencing transposable genetic elements.
In the cytoplasm, siRNA is processed from a double-stranded RNA, which comes from either endogenous DNA transcription or exogenous sources like a virus. This double-stranded RNA is then cleaved by the ATP-dependent...
RNA Interference01:23

RNA Interference

RNA interference (RNAi) is a process in which a small non-coding RNA molecule blocks the post-transcriptional expression of a gene by binding to its messenger RNA (mRNA) and preventing the protein from being translated.
This process occurs naturally in cells, often through the activity of genomically-encoded microRNAs. Researchers can take advantage of this mechanism by introducing synthetic RNAs to deactivate specific genes for research or therapeutic purposes. For example, RNAi could be used...
TGF - β Signaling Pathway01:16

TGF - β Signaling Pathway

The TGF-β signaling pathway regulates cell growth, differentiation, adhesion, motility, and development. TGF-β ligands that induce TGF-β signaling are synthesized in their latent form. Several proteases or cell surface receptors such as integrins act upon the latent form, releasing the active ligand. There are three types of mammalian TGF-βs: (TGF-β1, TGF-β2, and TGF-β3) that bind as homodimers or heterodimers to TGF-β receptors. The TGF-β receptors are of three kinds RI, RII, and RIII. The RI...
Regulation of Expression at Multiple Steps01:23

Regulation of Expression at Multiple Steps

The gene expression in cells is regulated at different stages: (i) transcription, (ii) RNA processing, (iii) RNA localization, and (iv) translation. Transcriptional regulation is mediated by regulatory proteins such as transcription factors, activators, or repressors—these control gene expression by initiating or inhibiting the transcription of genes. Once a precursor or pre-mRNA is produced, it undergoes post-transcriptional modification, including 5' capping, splicing, and the addition of a...